Diabetes Board decisions

The Veteran's diabetes mellitus and related neuropathy conditions have been granted a temporary increased rating of 40 percent from June 7, 2017 to November 5, 2019. Prior to this period, the Veteran's diabetes mellitus was rated at 20 percent, while his diabetic peripheral neuropathy has not met criteria for higher ratings.

The Board has remanded the issues of service connection for hypertension and erectile dysfunction, both claimed as secondary to type II diabetes mellitus.,Further development is needed to determine if these conditions are proximately due to or aggravated by the service-connected type II diabetes mellitus.

The Board has remanded the case due to incomplete development and the need for a new VA examination. The Veteran's diabetes mellitus type II, along with its complications such as neuropathy of the bilateral upper and lower extremities and hypertension, will be evaluated.

The Board has remanded the case due to insufficient medical opinions regarding the cause of death and the relationship between service-connected conditions and the Veteran's death.

The Board has granted service connection for ulcerative colitis, but denied the claims for hypertension, adenocarcinoma of the lung, neoplasm of the kidney, and diabetic nephropathy and renal dysfunction. The Veteran's preexisting ulcerative colitis was aggravated by service.

The Board denied the Veteran's claims for increased rating for service-connected diabetes mellitus and denial of service connection for kidney disease, finding no clear and unmistakable error in either decision.

The Board has decided to remand the case for a VA examination to assess the severity of the Veteran's service-connected diabetic polyneuropathy and differentiate between its effects from his service-connected disabilities and nonservice-connected conditions.

The Board has remanded the case due to insufficient medical opinions regarding the cause of the Veteran's death and a lack of clarification on access to his service treatment records prior to 2001. The VA must obtain an addendum opinion from a VA clinician to address these issues.

The Board has remanded the case due to a need for additional examination and opinion regarding whether the Veteran's service-connected disabilities, excluding diabetes and bilateral leg peripheral neuropathy, render him in need of regular aid and attendance. The Veteran is currently receiving SMC under Subsection (l) based on the need for aid and attendance.

The Board denied retroactive CRDP compensation payments for the period from August 1, 2013 to April 30, 2015 due to a correct adjustment by DFAS.

The Board has determined that more development is necessary for the claims of service connection for various disabilities, including diabetes mellitus, peripheral neuropathy, high blood pressure, arthritis, and kidney and bladder stones. The Veteran's exposure to non-ionizing radiation from radar equipment during his military service will be considered as part of this process.

The Board has granted the Veteran's claim for service connection for obstructive sleep apnea, finding that it was caused by his service-connected diabetes mellitus type I due to obesity. The bilateral factor applied resulted in a total combined rating of 90 percent.

The Board has remanded the Veteran's claims for diabetes and TDIU due to insufficient examination findings, including a failure to address obesity as an intermediate step in the causal chain.

The Board has granted service connection for the Veteran's lacunar infarcts, which are secondary to his service-connected diabetes mellitus type II. The decision is based on a finding of reasonable doubt in favor of the Veteran.

The Veteran's claim for service connection for diabetes mellitus type II, due to herbicide exposure, is being remanded for further development and consideration.

The Board has dismissed all claims of service connection and evaluation for the listed conditions due to the Veteran's withdrawal of his appeal.

The Veteran's diabetes mellitus type II is granted as presumptively related to his service in Vietnam due to exposure to herbicide agents, including Agent Orange.

The Board has remanded the Veteran's claims for increased ratings for peripheral neuropathy of the bilateral lower extremities and his claim for a TDIU due to outstanding VA treatment records and an assessment of the aggregate effect of his service-connected disabilities on his functionality.

The Board has remanded the Veteran's claims for increased ratings and effective date issues due to incomplete development or procedural errors.

The Board has remanded the Veteran's claims for diabetes mellitus due to insufficient medical opinions addressing the severity level of his disability.